CBD for menopause sleep: what the evidence really shows

There is very little evidence that CBD helps menopause sleep. No trial has tested it in perimenopausal or postmenopausal women, a small insomnia trial in other adults found it no better than placebo on most measures, and store-bought products are unregulated, often mislabeled and can interact with medicines. CBT-I and treating night sweats have far stronger support.

What CBD is

Cannabis contains more than 80 biologically active compounds. The two best known are THC, which produces the high associated with marijuana, and cannabidiol, or CBD, which does not. The FDA stresses that CBD and marijuana are not the same thing: CBD is a single compound, while marijuana is plant material containing many compounds, including both.

Since the 2018 Farm Bill, hemp, defined as cannabis with no more than 0.3% THC by dry weight, is no longer classed as marijuana under federal drug law. That did not make CBD a regulated health product. The FDA has approved only one CBD product, a prescription oral solution (Epidiolex) for seizures in three rare conditions: Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex. It says it is illegal to market CBD by adding it to food or labeling it as a dietary supplement, and that some CBD products are sold with unproven medical claims and are of unknown quality.

Why midlife women are trying it

Interest is real. In a 2022 survey of 131 perimenopausal and 127 postmenopausal people, 86.1% were current cannabis users and 78.7% used medical cannabis for menopause-related symptoms. Sleep problems were the most common target (67.4%), followed by mood and anxiety (46.1%). The most common ways of using it were smoking (84.3%) and edibles (78.3%), which suggests many were using THC-containing cannabis, not CBD alone.

Those numbers show what women hope cannabis will do. They cannot show whether it works, because the people surveyed were largely cannabis users, nobody was compared with a placebo, and many products contained THC. The researchers called for clinical trials.

What the research shows

Study	Who	What was tested	Finding
Systematic review, 2021	Perimenopausal and postmenopausal women	Any cannabis use	Only 3 small studies found; none tested CBD for sleep
Pilot randomized trial, 2024	30 adults with moderate to severe insomnia	150 mg CBD under the tongue 60 minutes before bed, for 2 weeks	No difference from placebo in insomnia severity, time to fall asleep, sleep efficiency by diary, or time awake at night
Position statement, 2023	Women with hot flashes and night sweats	Cannabinoids	Not recommended, because evidence is lacking

The menopause studies. A 2021 systematic review searched 10 databases and found 564 records, of which only three studies met its criteria. One looked at the effect of smoking cannabis or placebo cigarettes on mood in 10 postmenopausal women, one looked at drug use, hot flashes and insomnia in 120 women with HIV, and one asked 115 women what they expected cannabis to do. None measured whether CBD improves sleep. The authors concluded that cannabis is frequently used for menopause symptoms without evidence of benefit.

The insomnia trial. In the 2024 pilot trial, CBD did no better than placebo on insomnia severity or on sleep diary measures. The CBD group did report greater well-being, and wrist-worn activity monitors showed better sleep efficiency after 2 weeks, but most sleep outcomes did not change. With 15 people per group, it was too small to settle the question.

Night sweats. No trial has shown that CBD reduces hot flashes or night sweats. The Menopause Society’s 2023 nonhormone statement concluded that cannabinoids cannot be recommended for vasomotor symptoms.

Label accuracy: you may not get what you pay for

In a 2017 JAMA study, researchers bought 84 CBD products from 31 companies online and tested them:

• 31% contained the amount of CBD on the label, within a 10% margin.
• 43% contained more CBD than labeled, and 26% contained less, sometimes far less.
• THC was detected in 18 products (21%), at levels the authors said may be enough to cause intoxication or impairment, especially in children.
• Vape liquids were the most often mislabeled; oils were labeled accurately most often.

The market has changed since, but the FDA still describes many CBD products as being of unknown quality. If you are subject to workplace drug testing or simply want to avoid THC, a CBD label alone is not a guarantee. For what independent testing can and cannot tell you, see third-party testing explained.

Safety: liver, drug interactions and drowsiness

The FDA warns that CBD has the potential to cause harm, sometimes before you notice it.

Liver injury. In the trials of the prescription CBD drug, liver enzyme rises were dose-related and more common in people also taking the seizure medicine valproate. The label calls for liver blood tests before starting and at 1, 3 and 6 months. Healthy people are not exempt: in a small trial of 16 healthy adults taking 1,500 mg of CBD a day, 5 (31%) developed liver enzyme rises meeting criteria for drug-induced liver injury, all within 2 to 4 weeks. That dose is far higher than most store products, but it shows the risk is real.

Drug interactions. CBD is broken down by, and affects, liver enzymes that process many medicines.

Medicine	What can happen	Source
Clobazam (seizures)	Its active breakdown product rose about 3-fold	FDA drug label
Valproate (seizures, mood)	Higher risk of liver enzyme rises	FDA drug label
Clopidogrel (blood thinner)	May work less well	FDA drug label
Everolimus, sirolimus, tacrolimus (transplant, cancer)	Higher drug levels	FDA drug label
Warfarin (blood thinner)	Stronger effect and higher INR in one case report	Case report, 2018
Alcohol and sedatives, including sleep aids	More drowsiness and risk of injury	FDA

Other effects. The FDA lists sleepiness, diarrhea, decreased appetite, irritability and agitation as side effects that usually improve when CBD is stopped. It also notes male reproductive harm in animal studies, and unknowns about long-term daily use and effects on a fetus, which matters because pregnancy is still possible in perimenopause.

THC, impairment and driving

If a product contains THC, labeled or not, the CDC warns that cannabis can slow reaction time and decision-making, impair coordination and distort perception, all skills needed for driving. Studies link recent cannabis use with car crashes, and combining cannabis with alcohol increases impairment. Do not drive after using a product containing THC, and do not assume a CBD-only label means none is present.

If you still want to try CBD

• Talk to your clinician or pharmacist first, especially if you take any prescription medicine or have liver disease.
• Skip alcohol and do not combine CBD with sleep medicines without medical advice. See alcohol in perimenopause.
• Stop and seek care for signs of liver trouble listed on the prescription CBD label: unexplained nausea, vomiting, pain in the upper right abdomen, fatigue, loss of appetite, yellowing skin or eyes, or dark urine.
• Track it. Log two weeks before and after in your sleep diary to see whether anything actually changed.

Options with better evidence

CBT-I. Cognitive behavioral therapy for insomnia is the treatment with the strongest evidence for chronic insomnia. See CBT-I for menopause insomnia.

Treat night sweats. The Menopause Society calls hormone therapy the most effective treatment for hot flashes and night sweats, and recommends several nonhormone options. See night sweats and non-hormonal treatments for hot flashes.

Compare the rest. Our ranking of the best sleep aids for perimenopause covers prescription drugs, magnesium, melatonin and over-the-counter pills.

When to see a clinician

Book a visit if poor sleep has lasted more than a few weeks, if you snore or wake gasping, or if anxiety or low mood is part of the picture. A sleep medicine specialist can arrange CBT-I and test for sleep apnea.

Call 911 for severe drowsiness, confusion, trouble breathing or yellowing skin with severe abdominal pain. If you have thoughts of harming yourself, call or text 988.